Amir Sonnenblick

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Positive Breast Cancer

Endoplasmic Reticulum

Estrogen Receptor

Top Venues

NPJ breast cancer

Cancer discovery

International journal of cancer

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Lea Monteran, Nour Ershaid, Ye'ela Scharff, Yazeed Zoabi, Tamer Sanalla, Yunfeng Ding, Anna Pavlovsky, Yael Zait, Marva Langer, Tal Caller, Anat Eldar-Boock, Camila Avivi, Amir Sonnenblick, Ronit Satchi-Fainaro, Iris Barshack, Noam Shomron, Xiang H F Zhang, Neta Erez
Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity. Cancer discovery 14 (7) (2024)
Lea Monteran, Nour Ershaid, Ye'ela Scharff, Yazeed Zoabi, Tamer Sanalla, Yunfeng Ding, Anna Pavlovsky, Yael Zait, Marva Langer, Tal Caller, Anat Eldar-Boock, Camila Avivi, Amir Sonnenblick, Ronit Satchi-Fainaro, Iris Barshack, Noam Shomron, Xiang H F Zhang, Neta Erez
Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity. Cancer discovery 14 (7) (2024)
Lea Monteran, Nour Ershaid, Ye'ela Scharff, Yazeed Zoabi, Tamer Sanalla, Yunfeng Ding, Anna Pavlovsky, Yael Zait, Marva Langer, Tal Caller, Anat Eldar-Boock, Camila Avivi, Amir Sonnenblick, Ronit Satchi-Fainaro, Iris Barshack, Noam Shomron, Xiang H F Zhang, Neta Erez
Combining TIGIT blockage with MDSC inhibition hinders breast cancer bone metastasis by activating anti-tumor immunity. Cancer discovery (2024)
Ofer Rotem, Idit Peretz, Michelle Leviov, Iryna Kuchuk, Amit Itay, Margarita Tokar, Shani Paluch-Shimon, Ofra Maimon, Rinat Yerushalmi, Karen Drumea, Ella Evron, Amir Sonnenblick, Einav Gal-Yam, Hadar Goldvaser, Yosef Samih, Rotem Merose, Avital Bareket-Samish, Lior Soussan-Gutman, Salomon M Stemmer
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study. NPJ breast cancer 9 (1) (2023)
Shlomit Strulov Shachar, Michelle Leviov, Rinat Yerushalmi, Karen Drumea, Margarita Tokar, Lior Soussan-Gutman, Avital Bareket-Samish, Amir Sonnenblick, Noa Ben-Baruch, Ella Evron, Einav Nili Gal-Yam, Shani Paluch-Shimon, Gil Bar-Sela, Hadar Goldvaser, Salomon M Stemmer
Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry. NPJ breast cancer 9 (1) (2023)
Lea Monteran, Nour Ershaid, Hila Doron, Yael Zait, Ye'ela Scharff, Shahar Ben-Yosef, Camila Avivi, Iris Barshack, Amir Sonnenblick, Neta Erez
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer. Nature communications 13 (1) (2022)
Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Ariel M Rubinstein, Prudence A Francis, Angelo Di Leo, Giuseppe Viale, Evandro de Azambuja, Lieveke Ameye, Christos Sotiriou, Asher Salmon, Nataly Kravchenko-Balasha, Amir Sonnenblick
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer. NPJ breast cancer 7 (1) (2021)
Anat Shriki, Tali Lanton, Amir Sonnenblick, Orr Levkovitch-Siany, Dana Eidelshtein, Rinat Abramovitch, Nofar Rosenberg, Orit Pappo, Sharona Elgavish, Yuval Nevo, Rifaat Safadi, Amnon Peled, Stefan Rose-John, Eithan Galun, Jonathan H Axelrod
Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis. Cancer research 81 (18) (2021)
Shira Peleg Hasson, Tehillah Menes, Amir Sonnenblick
Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes. Pharmacogenomics and personalized medicine 13 (2020)
Gil Bar-Sela, Yousef Samih, Rinat Yerushalmi, Michelle Leviov, Noa Efrat Ben-Baruch, Iryna Kuchuk, Margarita Tokar, Tamar Peretz-Yablonski, Amir Sonnenblick, Lior Soussan-Gutman, Avital Bareket-Samish, Georgeta Fried, Shani Paluch-Shimon, Bella Kaufman, Ariel Hammerman, Nicky Liebermann, Salomon M Stemmer
Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis. The breast journal 26 (10) (2020)
Amir Sonnenblick, Mali Salmon-Divon, Roberto Salgado, Efrat Dvash, Noam Pondé, Tamar Zahavi, Asher Salmon, Sibylle Loibl, Carsten Denkert, Heikki Joensuu, Lieveke Ameye, Gert Van den Eynden, Pirkko-Liisa Kellokumpu-Lehtinen, Amos Azaria, Sherene Loi, Stefan Michiels, François Richard, Christos Sotiriou
Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer. International journal of cancer 147 (1) (2020)
Amir Sonnenblick, Dominique Agbor-Tarh, Evandro de Azambuja, Susanne Hultsch, Miguel Izquierdo, Minetta Liu, Giancarlo Pruneri, Nadia Harbeck, Martine Piccart, Alvaro Moreno-Aspita, Roy Zvi Granit, Ghizlane Rouas, Ibrahim Fahoum, Christos Sotiriou
STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial. International journal of cancer 148 (6) (2020)
Nadav Michaan, Moshe Leshno, Tamar Safra, Amir Sonnenblick, Ido Laskov, Dan Grisaru
Cost Effectiveness of Whole Population BRCA Genetic Screening for Cancer Prevention in Israel. Cancer prevention research (Philadelphia, Pa.) 14 (4) (2020)
Amir Sonnenblick, David Venet, Sylvain Brohée, Noam Pondé, Christos Sotiriou
pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation. NPJ breast cancer 5 (2019)